Nexalis Therapeutics Limited has released a press release.
Lifespot Signs Global Agreement With Beurer
Filed with ASX ·
6ix hasn’t read this filing yet.
Nexalis Therapeutics Limited on 6ix
Story so far
Earlier from Nexalis Therapeutics
- Digital Health Consortium Formed To Target $3.5B Market
- Business & Operational Update
- LSH enters $50Bn Global Medicinal Cannabis market
- Update on Medicinal Cannabis opportunities
- Exploring opportunities in Medicinal Cannabis
Later from Nexalis Therapeutics
- Lifespot Health restructures its Business and Board
- New Patient Self-Management System Launched
- Update on development of unique cannabis vaporizer
- Amended Appendix 4C - Cash balance at 31/3 $3.904M
- Unique cannabis vaporizer under evaluation in Israel
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics